{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:39:23Z","timestamp":1791607163886,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172971"],"award-info":[{"award-number":["82172971"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31671348"],"award-info":[{"award-number":["31671348"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874189"],"award-info":[{"award-number":["81874189"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chen Xiao-ping Foundation for the Development of Science and Technology of Hubei Province","award":["CXPJJH12000001-2020317"],"award-info":[{"award-number":["CXPJJH12000001-2020317"]}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["(2018ZX10723204-003"],"award-info":[{"award-number":["(2018ZX10723204-003"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2018YFA0208904"],"award-info":[{"award-number":["2018YFA0208904"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundamental Research Funds for the Central Universities, HUST","award":["2020JYCXJJ019"],"award-info":[{"award-number":["2020JYCXJJ019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>MicroRNAs (miRNAs) play crucial roles in the development of hepatocellular carcinoma (HCC). Hsa-microRNA-27b-3p (<jats:italic>hsa-miR-27b<\/jats:italic>) is involved in the formation and progression of various cancers, but its role and clinical value in HCC remain unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The expression of <jats:italic>hsa-miR-27b<\/jats:italic> in HCC was examined by quantitative real-time PCR (qRT-PCR) and in\u00a0situ hybridization (ISH) assays of clinical samples. Cell Counting Kit-8 assays (CCK-8), 5-ethynyl-2\u2032-deoxyuridine (EdU) incorporation assays, Transwell assays, filamentous actin (<jats:italic>F-actin<\/jats:italic>) staining and western blot analyses were used to determine the effects of <jats:italic>hsa-miR-27b<\/jats:italic> on HCC cells in\u00a0vitro. Subcutaneous xenograft and lung metastatic animal experiments were conducted to verify the role of <jats:italic>hsa-miR-27b<\/jats:italic> in HCC in\u00a0vivo. In\u00a0silico prediction, qRT-PCR, western blot, anti-Argonaute 2 (<jats:italic>AGO2<\/jats:italic>) RNA immunoprecipitation (RIP) and dual luciferase reporter assays were applied to identify the target genes of <jats:italic>hsa-miR-27b<\/jats:italic>. To detect the impacts of <jats:italic>hsa-miR-27b<\/jats:italic> on nuclear factor kappa B (<jats:italic>NF-\u043aB<\/jats:italic>) signalling cascades mediated by transforming growth factor-activated kinase-binding protein 3 (<jats:italic>TAB3<\/jats:italic>), we performed qRT-PCR, western blot assays, immunofluorescence staining, immunohistochemistry (IHC) and dual-luciferase reporter assays. Recombinant oncolytic adenovirus (Onco<jats:sup>Ad<\/jats:sup>) overexpressing <jats:italic>hsa-miR-27b<\/jats:italic> was constructed to detect their therapeutic value in HCC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The expression of <jats:italic>hsa-miR-27b<\/jats:italic> was lower in HCC than in adjacent non-tumourous tissues (ANTs), and the reduced expression of <jats:italic>hsa-miR-27b<\/jats:italic> was associated with worse outcomes in patients with HCC. <jats:italic>Hsa-miR-27b<\/jats:italic> significantly inhibited the proliferation, migration, invasion, subcutaneous tumour growth and lung metastasis of HCC cells. The suppression of <jats:italic>hsa-miR-27b<\/jats:italic> promoted the nuclear translocation of <jats:italic>NF-\u03baB<\/jats:italic> by upregulating <jats:italic>TAB3<\/jats:italic> expression. <jats:italic>TAB3<\/jats:italic> was highly expressed in HCC compared with ANTs and was negatively correlated with the expression of <jats:italic>hsa-miR-27b<\/jats:italic>. The impaired cell proliferation, migration and invasion by <jats:italic>hsa-miR-27b<\/jats:italic> overexpression were recovered by ectopic expression of <jats:italic>TAB3<\/jats:italic>. Recombinant Onco<jats:sup>Ad<\/jats:sup> with overexpression of <jats:italic>hsa-miR-27b<\/jats:italic> induced anti-tumour activity compared with that induced by negative control (NC) Onco<jats:sup>Ad<\/jats:sup> in\u00a0vivo and in\u00a0vitro.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>By targeting <jats:italic>TAB3<\/jats:italic>, <jats:italic>hsa-miR-27b<\/jats:italic> acted as a tumour suppressor by inactivating the <jats:italic>NF-\u043aB<\/jats:italic> pathway in HCC in\u00a0vitro and in\u00a0vivo, indicating its therapeutic value against HCC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s11658-022-00370-4","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T23:03:41Z","timestamp":1663887821000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Hsa-microRNA-27b-3p inhibits hepatocellular carcinoma progression by inactivating transforming growth factor-activated kinase-binding protein 3\/nuclear factor kappa B signalling"],"prefix":"10.1186","volume":"27","author":[{"given":"Jingyuan","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junnan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1609-7260","authenticated-orcid":false,"given":"Bixiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"370_CR1","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1053\/j.gastro.2004.09.011","volume":"127","author":"FX Bosch","year":"2004","unstructured":"Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127:S5\u201316.","journal-title":"Gastroenterology"},{"key":"370_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"370_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281\u201397.","journal-title":"Cell"},{"key":"370_CR4","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nrm1644","volume":"6","author":"VN Kim","year":"2005","unstructured":"Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol. 2005;6:376\u201385.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"370_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nature07242","volume":"455","author":"D Baek","year":"2008","unstructured":"Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature. 2008;455:64\u201371.","journal-title":"Nature"},{"key":"370_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2015.05.001","volume":"87","author":"SM Hammond","year":"2015","unstructured":"Hammond SM. An overview of microRNAs. Adv Drug Deliv Rev. 2015;87:3\u201314.","journal-title":"Adv Drug Deliv Rev"},{"key":"370_CR7","doi-asserted-by":"publisher","first-page":"BSR20191087","DOI":"10.1042\/BSR20191087","volume":"39","author":"X Yang","year":"2019","unstructured":"Yang X, Chen J, Liao Y, Huang L, Wen C, Lin M, Li W, et\u00a0al. miR-27b-3p promotes migration and invasion in colorectal cancer cells by targeting HOXA10. Biosci Rep. 2019;39:BSR20191087.","journal-title":"Biosci Rep"},{"key":"370_CR8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41419-017-0211-4","volume":"9","author":"D Chen","year":"2018","unstructured":"Chen D, Si W, Shen J, Du C, Lou W, Bao C, Zheng H, et\u00a0al. miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB\/GRB2 in breast cancer cells. Cell Death Dis. 2018;9:188.","journal-title":"Cell Death Dis"},{"key":"370_CR9","first-page":"4113","volume":"21","author":"Y Sun","year":"2017","unstructured":"Sun Y, Xu T, Cao YW, Ding XQ. Antitumor effect of miR-27b-3p on lung cancer cells via targeting Fzd7. Eur Rev Med Pharmacol Sci. 2017;21:4113\u201323.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"370_CR10","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1158\/0008-5472.CAN-12-2162","volume":"73","author":"L Jin","year":"2013","unstructured":"Jin L, Wessely O, Marcusson EG, Ivan C, Calin GA, Alahari SK. Prooncogenic factors miR-23b and miR-27b are regulated by Her2\/Neu, EGF, and TNF-\u03b1 in breast cancer. Cancer Res. 2013;73:2884\u201396.","journal-title":"Cancer Res"},{"key":"370_CR11","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3892\/ijo.2015.3162","volume":"47","author":"S Zhang","year":"2015","unstructured":"Zhang S, Liu F, Mao X, Huang J, Yang J, Yin X, Wu L, et\u00a0al. Elevation of miR-27b by HPV16 E7 inhibits PPAR\u03b3 expression and promotes proliferation and invasion in cervical carcinoma cells. Int J Oncol. 2015;47:1759\u201366.","journal-title":"Int J Oncol"},{"key":"370_CR12","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1038\/onc.2011.543","volume":"31","author":"JJ Lee","year":"2012","unstructured":"Lee JJ, Drakaki A, Iliopoulos D, Struhl K. miR-27b targets PPAR\u03b3 to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cells. Oncogene. 2012;31:3818\u201325.","journal-title":"Oncogene"},{"key":"370_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s13238-016-0340-z","volume":"8","author":"Q Feng","year":"2017","unstructured":"Feng Q, Wu X, Li F, Ning B, Lu X, Zhang Y, Pan Y, et\u00a0al. miR-27b inhibits gastric cancer metastasis by targeting NR2F2. Protein Cell. 2017;8:114\u201322.","journal-title":"Protein Cell"},{"key":"370_CR14","doi-asserted-by":"publisher","first-page":"15325","DOI":"10.1007\/s13277-016-5444-9","volume":"37","author":"XF Sun","year":"2016","unstructured":"Sun XF, Sun JP, Hou HT, Li K, Liu X, Ge QX. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma. Tumour Biol. 2016;37:15325\u201332.","journal-title":"Tumour Biol"},{"key":"370_CR15","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.3892\/mmr.2016.4851","volume":"13","author":"S He","year":"2016","unstructured":"He S, Zhang J, Lin J, Zhang C, Sun S. Expression and function of microRNA-27b in hepatocellular carcinoma. Mol Med Rep. 2016;13:2801\u20138.","journal-title":"Mol Med Rep"},{"key":"370_CR16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/CAD.0000000000000711","volume":"30","author":"H Liang","year":"2019","unstructured":"Liang H, Ai-Jun J, Ji-Zong Z, Jian-Bo H, Liang Z, Yong-Xiang Y, Chen Y. Clinicopathological significance of miR-27b targeting Golgi protein 73 in patients with hepatocellular carcinoma. Anticancer Drugs. 2019;30:186\u201394.","journal-title":"Anticancer Drugs"},{"key":"370_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/cr.2015.23","volume":"25","author":"W Mu","year":"2015","unstructured":"Mu W, Hu C, Zhang H, Qu Z, Cen J, Qiu Z, Li C, et\u00a0al. miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression. Cell Res. 2015;25:477\u201395.","journal-title":"Cell Res"},{"key":"370_CR18","doi-asserted-by":"publisher","first-page":"8575","DOI":"10.2147\/CMAR.S321111","volume":"13","author":"C Fu","year":"2021","unstructured":"Fu C, Li J, Li P, Cheng D. LncRNA DNAJC3-AS1 promotes hepatocellular carcinoma (HCC) progression via sponging premature miR-27b. Cancer Manag Res. 2021;13:8575\u201383.","journal-title":"Cancer Manag Res"},{"key":"370_CR19","doi-asserted-by":"publisher","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T. The nuclear factor NF-\u03baB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1:a001651.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"370_CR20","doi-asserted-by":"publisher","first-page":"5735","DOI":"10.2174\/138161212803530763","volume":"18","author":"C Gasparini","year":"2012","unstructured":"Gasparini C, Feldmann M. NF-\u03baB as a target for modulating inflammatory responses. Curr Pharm Des. 2012;18:5735\u201345.","journal-title":"Curr Pharm Des"},{"key":"370_CR21","doi-asserted-by":"publisher","first-page":"7294","DOI":"10.18632\/aging.102266","volume":"11","author":"W Yi","year":"2019","unstructured":"Yi W, Wen Y, Tan F, Liu X, Lan H, Ye H, Liu B. Impact of NF-\u03baB pathway on the apoptosis\u2013inflammation\u2013autophagy crosstalk in human degenerative nucleus pulposus cells. Aging (Albany NY). 2019;11:7294\u2013306.","journal-title":"Aging (Albany NY)"},{"key":"370_CR22","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/sj.cdd.4401888","volume":"13","author":"V Bottero","year":"2006","unstructured":"Bottero V, Withoff S, Verma IM. NF-\u03baB and the regulation of hematopoiesis. Cell Death Differ. 2006;13:785\u201397.","journal-title":"Cell Death Differ"},{"key":"370_CR23","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","volume":"2","author":"Y Xia","year":"2014","unstructured":"Xia Y, Shen S, Verma IM. NF-\u03baB, an active player in human cancers. Cancer Immunol Res. 2014;2:823\u201330.","journal-title":"Cancer Immunol Res"},{"key":"370_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrc3204","volume":"12","author":"ND Perkins","year":"2012","unstructured":"Perkins ND. The diverse and complex roles of NF-\u03baB subunits in cancer. Nat Rev Cancer. 2012;12:121\u201332.","journal-title":"Nat Rev Cancer"},{"key":"370_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1476-4598-13-35","volume":"13","author":"N Zhao","year":"2014","unstructured":"Zhao N, Wang R, Zhou L, Zhu Y, Gong J, Zhuang SM. MicroRNA-26b suppresses the NF-\u03baB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3. Mol Cancer. 2014;13:35.","journal-title":"Mol Cancer"},{"key":"370_CR26","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/hep.26378","volume":"58","author":"J Ding","year":"2013","unstructured":"Ding J, Huang S, Wang Y, Tian Q, Zha R, Shi H, Wang Q, et\u00a0al. Genome-wide screening reveals that miR-195 targets the TNF-\u03b1\/NF-\u03baB pathway by down-regulating I\u03baB kinase \u03b1 and TAB3 in hepatocellular carcinoma. Hepatology. 2013;58:654\u201366.","journal-title":"Hepatology"},{"key":"370_CR27","first-page":"2876","volume":"40","author":"J Zhao","year":"2018","unstructured":"Zhao J, Gai L, Gao Y, Xia W, Shen D, Lin Q, Mao W, et\u00a0al. TAB3 promotes human esophageal squamous cell carcinoma proliferation and invasion via the NF\u03baB pathway. Oncol Rep. 2018;40:2876\u201385.","journal-title":"Oncol Rep"},{"key":"370_CR28","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1007\/s13277-015-3896-y","volume":"37","author":"J Chen","year":"2016","unstructured":"Chen J, Gu J, Feng J, Liu Y, Xue Q, Ni T, Wang Z, et\u00a0al. TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-\u03baB pathway. Tumour Biol. 2016;37:3851\u201361.","journal-title":"Tumour Biol"},{"key":"370_CR29","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1073\/pnas.0307314101","volume":"101","author":"G Jin","year":"2004","unstructured":"Jin G, Klika A, Callahan M, Faga B, Danzig J, Jiang Z, Li X, et\u00a0al. Identification of a human NF-\u03baB-activating protein, TAB3. Proc Natl Acad Sci USA. 2004;101:2028\u201333.","journal-title":"Proc Natl Acad Sci USA"},{"key":"370_CR30","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1111\/febs.15202","volume":"287","author":"Q Zhou","year":"2020","unstructured":"Zhou Q, Cheng C, Wei Y, Yang J, Zhou W, Song Q, Ke M, et\u00a0al. USP15 potentiates NF-\u03baB activation by differentially stabilizing TAB2 and TAB3. FEBS J. 2020;287:3165\u201383.","journal-title":"FEBS J"},{"key":"370_CR31","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.1038\/emboj.2011.413","volume":"30","author":"A Criollo","year":"2011","unstructured":"Criollo A, Niso-Santano M, Malik SA, Michaud M, Morselli E, Marino G, Lachkar S, et\u00a0al. Inhibition of autophagy by TAB2 and TAB3. EMBO J. 2011;30:4908\u201320.","journal-title":"EMBO J"},{"key":"370_CR32","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/cpr.12293","volume":"49","author":"Y Chen","year":"2016","unstructured":"Chen Y, Wang X, Duan C, Chen J, Su M, Jin Y, Deng Y, et\u00a0al. Loss of TAB3 expression by shRNA exhibits suppressive bioactivity and increased chemical sensitivity of ovarian cancer cell lines via the NF-\u03baB pathway. Cell Prolif. 2016;49:657\u201368.","journal-title":"Cell Prolif"},{"key":"370_CR33","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1038\/sj.onc.1210413","volume":"26","author":"A Adhikari","year":"2007","unstructured":"Adhikari A, Xu M, Chen ZJ. Ubiquitin-mediated activation of TAK1 and IKK. Oncogene. 2007;26:3214\u201326.","journal-title":"Oncogene"},{"key":"370_CR34","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/hep.27273","volume":"60","author":"ZY Ding","year":"2014","unstructured":"Ding ZY, Jin GN, Wang W, Chen WX, Wu YH, Ai X, Chen L, et\u00a0al. Reduced expression of transcriptional intermediary factor 1 \u03b3 promotes metastasis and indicates poor prognosis of hepatocellular carcinoma. Hepatology. 2014;60:1620\u201336.","journal-title":"Hepatology"},{"key":"370_CR35","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13046-020-01649-0","volume":"39","author":"Z Huang","year":"2020","unstructured":"Huang Z, Wen J, Yu J, Liao J, Liu S, Cai N, Liang H, et\u00a0al. MicroRNA-148a-3p inhibits progression of hepatocellular carcinoma by repressing SMAD2 expression in an Ago2 dependent manner. J Exp Clin Cancer Res. 2020;39:150.","journal-title":"J Exp Clin Cancer Res"},{"key":"370_CR36","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/s41418-022-00929-w","volume":"29","author":"J Liang","year":"2022","unstructured":"Liang J, Li G, Liao J, Huang Z, Wen J, Wang Y, Chen Z, et\u00a0al. Non-coding small nucleolar RNA SNORD17 promotes the progression of hepatocellular carcinoma through a positive feedback loop upon p53 inactivation. Cell Death Differ. 2022;29:988\u20131003.","journal-title":"Cell Death Differ"},{"key":"370_CR37","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.jhep.2016.05.007","volume":"65","author":"G Giannelli","year":"2016","unstructured":"Giannelli G, Koudelkova P, Dituri F, Mikulits W. Role of epithelial to mesenchymal transition in hepatocellular carcinoma. J Hepatol. 2016;65:798\u2013808.","journal-title":"J Hepatol"},{"key":"370_CR38","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nature12080","volume":"497","author":"J Shen","year":"2013","unstructured":"Shen J, Xia W, Khotskaya YB, Huo L, Nakanishi K, Lim SO, Du Y, et\u00a0al. EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature. 2013;497:383\u20137.","journal-title":"Nature"},{"key":"370_CR39","doi-asserted-by":"publisher","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","volume":"18","author":"HL Pahl","year":"1999","unstructured":"Pahl HL. Activators and target genes of Rel\/NF-\u03baB transcription factors. Oncogene. 1999;18:6853\u201366.","journal-title":"Oncogene"},{"key":"370_CR40","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1074\/jbc.M608867200","volume":"282","author":"A Besse","year":"2007","unstructured":"Besse A, Lamothe B, Campos AD, Webster WK, Maddineni U, Lin SC, Wu H, et\u00a0al. TAK1-dependent signaling requires functional interaction with TAB2\/TAB3. J Biol Chem. 2007;282:3918\u201328.","journal-title":"J Biol Chem"},{"key":"370_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coviro.2016.06.009","volume":"21","author":"A Rosewell Shaw","year":"2016","unstructured":"Rosewell Shaw A, Suzuki M. Recent advances in oncolytic adenovirus therapies for cancer. Curr Opin Virol. 2016;21:9\u201315.","journal-title":"Curr Opin Virol"},{"key":"370_CR42","doi-asserted-by":"publisher","first-page":"101042831769165","DOI":"10.1177\/1010428317691657","volume":"39","author":"L Ding","year":"2017","unstructured":"Ding L, Ni J, Yang F, Huang L, Deng H, Wu Y, Ding X, et\u00a0al. Promising therapeutic role of miR-27b in tumor. Tumour Biol. 2017;39:1010428317691657.","journal-title":"Tumour Biol"},{"key":"370_CR43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13046-015-0253-3","volume":"34","author":"J Tao","year":"2015","unstructured":"Tao J, Zhi X, Zhang X, Fu M, Huang H, Fan Y, Guan W, et\u00a0al. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer. J Exp Clin Cancer Res. 2015;34:139.","journal-title":"J Exp Clin Cancer Res"},{"key":"370_CR44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s11658-018-0077-1","volume":"23","author":"W Feng","year":"2018","unstructured":"Feng W, Xue T, Huang S, Shi Q, Tang C, Cui G, Yang G, et\u00a0al. HIF-1\u03b1 promotes the migration and invasion of hepatocellular carcinoma cells via the IL-8\u2013NF-\u03baB axis. Cell Mol Biol Lett. 2018;23:26.","journal-title":"Cell Mol Biol Lett"},{"key":"370_CR45","first-page":"118","volume":"10","author":"L Gao","year":"2020","unstructured":"Gao L, Zhao H, Sun H, Huang Y. TAB3 overexpression promotes NF-\u03baB activation and inflammation in acute pancreatitis. Am J Blood Res. 2020;10:118\u201323.","journal-title":"Am J Blood Res"},{"key":"370_CR46","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/glia.22451","volume":"61","author":"G Shi","year":"2013","unstructured":"Shi G, Shi J, Liu K, Liu N, Wang Y, Fu Z, Ding J, et\u00a0al. Increased miR-195 aggravates neuropathic pain by inhibiting autophagy following peripheral nerve injury. Glia. 2013;61:504\u201312.","journal-title":"Glia"},{"key":"370_CR47","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.bbrc.2014.12.119","volume":"457","author":"L Zhao","year":"2015","unstructured":"Zhao L, Zhang Y. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-\u03baB pathway. Biochem Biophys Res Commun. 2015;457:370\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"370_CR48","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16:203\u201322.","journal-title":"Nat Rev Drug Discov"},{"key":"370_CR49","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00109-012-0985-x","volume":"91","author":"W Lou","year":"2013","unstructured":"Lou W, Chen Q, Ma L, Liu J, Yang Z, Shen J, Cui Y, et\u00a0al. Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model. J Mol Med (Berl). 2013;91:715\u201325.","journal-title":"J Mol Med (Berl)"},{"key":"370_CR50","doi-asserted-by":"publisher","first-page":"e73964","DOI":"10.1371\/journal.pone.0073964","volume":"8","author":"E Callegari","year":"2013","unstructured":"Callegari E, Elamin BK, D\u2019Abundo L, Falzoni S, Donvito G, Moshiri F, Milazzo M, et\u00a0al. Anti-tumor activity of a miR-199-dependent oncolytic adenovirus. PLoS ONE. 2013;8:e73964.","journal-title":"PLoS ONE"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-022-00370-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-022-00370-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-022-00370-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:03:10Z","timestamp":1663891390000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmbl.biomedcentral.com\/articles\/10.1186\/s11658-022-00370-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["370"],"URL":"https:\/\/doi.org\/10.1186\/s11658-022-00370-4","relation":{},"ISSN":["1425-8153","1689-1392"],"issn-type":[{"value":"1425-8153","type":"print"},{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"assertion":[{"value":"3 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experimental procedures were performed in accordance with the Basel Declaration, and was also approved by the Committee on the Ethics of Animal Experiments of Tongji Hospital (TJH-202005005, 2 March 2020). All human tissue samples were obtained in accordance with the Declaration of Helsinki (1975), and were approved by the ethics committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (Wuhan, China) (TJ-IRB20211163, 30 November 2021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}